Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High?
Portfolio Pulse from
Wall Street analysts predict a 27.84% upside for Haemonetics (HAE) based on average price targets. Despite skepticism about the metric's effectiveness, positive earnings estimate revisions could support this potential increase.
December 04, 2024 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Haemonetics (HAE) is projected to have a 27.84% upside according to Wall Street analysts' average price targets. Positive earnings estimate revisions may support this potential increase.
The article highlights a significant potential upside for HAE based on analyst price targets, which is further supported by positive trends in earnings estimate revisions. This combination suggests a likely positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100